DOI QR코드

DOI QR Code

Specification and Testing Method of WHW ex. for Chronic Renal Failure

만성신부전 치료제 개발을 위한 WHW 엑스의 기준 및 시험방법 설정

  • Published : 2009.06.20

Abstract

This study is to specify the criteria and testing methods of WHW extract which has a potency as a therapeutic agent for chronic renal failure. The determination of specifications of WHW extract is mostly important because of the quality assurance. Three batches of WHW extract were obtained by the extraction at $98^{\circ}$C for 3 hr using water from mixture of 15 herbal medicines including Codonopsis Pilosulae Radix, Salviae Radix, Pinelliae Rhizoma, Coptidis Rhizoma, Evodiae Fructus, Epimedii Herba, Rhei Rhizoma, Perillae Herba, Glycyrrhizae Radix, Artemixiae capillaris Herba, Alimatis Rhizoma, Hoelen, Atractylodies Rhizoma alba, Polyporus and Cinnamomi Ramulus, subsequently, vaccum-dried for 15 hr. The yield of WHW extracts was 24.53% on the average. The identification of each herbal medicine of WHW extract was performed by modification of Korean Pharmacopeia IX (KP IX). The assay of WHW extract was performed using standard such as berberine, icariin, glycyrrhizin, and cinnamic acid of indicative herbal medicines by modification of KP IX, too. As well as, paticle size classification test was carried out to indicate the boundary of particle size of WHW extract and the particle size of WHW extract more than 50% showed the 140 ${\mu}$m. Taken together, WHW extract could be prepared reproducibly and assurable if follows the presented extraction and drying steps and its specifications were satisfied with the indicated criteria.

Keywords

References

  1. J.Y. Guh, H.C. Chen, J.F. Tsai and L.Y. Chuang, Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan, Am. J. Kidney Disl., 49(5), 626-633 (2007) https://doi.org/10.1053/j.ajkd.2007.02.259
  2. P.A. McCullough, S. Li, C.T. Jurkovitz, L. Stevens, A.J. Collins, S.C. Chen, K.C. Norris, S. McFarlane, B. Johnson, M.G. Shlipak, C.I. Obialo, W.W. Brown, J. Vassaloti, A.T. Whaley-Connell, R.M. Brenner and G.L. Bakris, KEEP Investigators, Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to shortterm mortality, Am. Heart J., 156(2), 277-283 (2008) https://doi.org/10.1016/j.ahj.2008.02.024
  3. A. Zuccala, F. Losinno, S. Fiorenza, F. Lifrieri and R. Rapanà, Hypertention in a female patient with renal failure, G. Ital. Nefrol., 22(6), 617-620 (2005)
  4. P. Wesolowski, M. Saracyn, Z. Nowak and Z. Wankowicz, Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy, Pol. Merkur. Lekarski., 24(142), 359-363 (2008)
  5. Y. Nakayama, T. Inoue, Y. Kohda, H. Inoue, Y. Izumi, K. Tomita and H. Nonoguchi, Long-term observation of renal function on combination therapy with prostaglandin and angiotensin-converting enzyme inhibitor for chronic kidney disease, Clin. Nephrol., 69(6), 402-407 (2008) https://doi.org/10.5414/CNP69402
  6. N.R. Robles, Calcium antagonists and renal failure progression, Ren. Fail., 30(3), 247-255 (2008) https://doi.org/10.1080/08860220701856946
  7. B.F. Palmer, Supratherapeutic doses of angiotensin receptor blockers to decrease proteinuria in patients with chronic kidney disease, Am. J. Nephrol., 28(3), 381-390 (2008) https://doi.org/10.1159/000112270
  8. Q. Li, D. Wang, Y. Wang and Q. Xu, Simvastatin down regulates mRNA expression of RANTES and CCR5 in posttransplant renal recipients with hyperlipidemia, Transplant Proc., 38(9), 2899-2904 (2006) https://doi.org/10.1016/j.transproceed.2006.08.136
  9. Y.M. Seok, J. Kim, M.J. Park, Y.C. Boo, Y.K. Park and K.M. Park, Wen-pi-tang-Hab-Wu-ling-san attenuates kidney mice, Phytother Res., 22(8), 1057-1063 (2008) https://doi.org/10.1002/ptr.2440
  10. H.W. Jung, C.H. Yoon, Y.H. Kim, Y.C. Boo, K.M. Park and Y.K. Park, Wen-Pi-Tang-Hab-Wu-Ling-San extract inhibits the release of inflammatory mediators from LPS-stimulated mouse macrophages, J. Ethnopharmacol., 114(3), 439-445 (2007) https://doi.org/10.1016/j.jep.2007.08.035
  11. Y.M. Seok, J. Kim, K.C. Choi, C.H. Yoon, Y.C. Boo, Y. Park and K.M. Park, Wen-pi-tang-Hab-Wu-ling-san attenuates kidney ischemia/reperfusion injury in mice. A role for antioxidant enzymes and heat-shock proteins, J. Ethnopharmacol., 112(2), 333-340 (2007) https://doi.org/10.1016/j.jep.2007.03.015
  12. Y. Naiki, Y. Maeda, K. Matsuo, S. Yonekawa, M. Sakaguchi, I. Iwamoto, H. Hasegawa and A. Kanamaru, Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis, J. Nephrol., 16(1), 95-102 (2003)
  13. 대한약전 제9개정 해설서, 2008, 한국약학대학협의회, 약전분과회 편저, 신일상사
  14. 대한약전외한약(생약)규격집, 2005, 식품의약품안전청